Direction of outward FDI of EMNEs: evidence from the Indian pharmaceutical sector

Sumon Bhaumik, Nigel Driffield

Research output: Contribution to journalArticle

Abstract

This article seeks to add to the small but growing literature of emerging-market multinational enterprises (EMNEs). Using two linked large firm-level databases, it seeks to explore the determinants of outward investment of Indian pharmaceutical companies, distinguishing between developed- versus developing-country destinations. It specifically examines the impact of two firm-level characteristics that embody “non-OLI” [ownership, location, and internalization] firm-specific capabilities of EMNEs. The finding of this study is that family firms are keen on investing in other developing countries but much less so in developed countries. However, international linkages in the form of foreign investors offset this.
Original languageEnglish
Pages (from-to)615-628
Number of pages14
JournalThunderbird International Business Review
Volume53
Issue number5
Early online date18 Aug 2011
DOIs
Publication statusPublished - Sep 2011

Fingerprint

multinational enterprise
pharmaceutical
drug
firm
market
evidence
developing world
developing country
internalization
investor
ownership
determinants
Multinational enterprises
Pharmaceuticals
Emerging market multinationals
Outward FDI
Developing countries
Destination
Ownership
Family firms

Bibliographical note

Bhaumik, S., & Driffield, N. (2011). Direction of outward FDI of EMNEs: evidence from the Indian pharmaceutical sector. Thunderbird international business review, 53(5), 615-628. © 2011 Wiley Periodicals, Inc.

Cite this

@article{dcdab667f2aa4db093a479fd6cb36b30,
title = "Direction of outward FDI of EMNEs: evidence from the Indian pharmaceutical sector",
abstract = "This article seeks to add to the small but growing literature of emerging-market multinational enterprises (EMNEs). Using two linked large firm-level databases, it seeks to explore the determinants of outward investment of Indian pharmaceutical companies, distinguishing between developed- versus developing-country destinations. It specifically examines the impact of two firm-level characteristics that embody “non-OLI” [ownership, location, and internalization] firm-specific capabilities of EMNEs. The finding of this study is that family firms are keen on investing in other developing countries but much less so in developed countries. However, international linkages in the form of foreign investors offset this.",
author = "Sumon Bhaumik and Nigel Driffield",
note = "Bhaumik, S., & Driffield, N. (2011). Direction of outward FDI of EMNEs: evidence from the Indian pharmaceutical sector. Thunderbird international business review, 53(5), 615-628. {\circledC} 2011 Wiley Periodicals, Inc.",
year = "2011",
month = "9",
doi = "10.1002/tie.20438",
language = "English",
volume = "53",
pages = "615--628",
journal = "Thunderbird International Business Review",
issn = "1096-4762",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

Direction of outward FDI of EMNEs : evidence from the Indian pharmaceutical sector. / Bhaumik, Sumon; Driffield, Nigel.

In: Thunderbird International Business Review, Vol. 53, No. 5, 09.2011, p. 615-628.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Direction of outward FDI of EMNEs

T2 - evidence from the Indian pharmaceutical sector

AU - Bhaumik, Sumon

AU - Driffield, Nigel

N1 - Bhaumik, S., & Driffield, N. (2011). Direction of outward FDI of EMNEs: evidence from the Indian pharmaceutical sector. Thunderbird international business review, 53(5), 615-628. © 2011 Wiley Periodicals, Inc.

PY - 2011/9

Y1 - 2011/9

N2 - This article seeks to add to the small but growing literature of emerging-market multinational enterprises (EMNEs). Using two linked large firm-level databases, it seeks to explore the determinants of outward investment of Indian pharmaceutical companies, distinguishing between developed- versus developing-country destinations. It specifically examines the impact of two firm-level characteristics that embody “non-OLI” [ownership, location, and internalization] firm-specific capabilities of EMNEs. The finding of this study is that family firms are keen on investing in other developing countries but much less so in developed countries. However, international linkages in the form of foreign investors offset this.

AB - This article seeks to add to the small but growing literature of emerging-market multinational enterprises (EMNEs). Using two linked large firm-level databases, it seeks to explore the determinants of outward investment of Indian pharmaceutical companies, distinguishing between developed- versus developing-country destinations. It specifically examines the impact of two firm-level characteristics that embody “non-OLI” [ownership, location, and internalization] firm-specific capabilities of EMNEs. The finding of this study is that family firms are keen on investing in other developing countries but much less so in developed countries. However, international linkages in the form of foreign investors offset this.

UR - http://www.scopus.com/inward/record.url?scp=84860407685&partnerID=8YFLogxK

U2 - 10.1002/tie.20438

DO - 10.1002/tie.20438

M3 - Article

VL - 53

SP - 615

EP - 628

JO - Thunderbird International Business Review

JF - Thunderbird International Business Review

SN - 1096-4762

IS - 5

ER -